McDermott Will & Schulte, a global law firm

When compliance or enforcement matters arise, Jamie takes a proactive, business-focused approach to address the issues with minimal business disruption. He also works with clients on the regulatory components of internal investigations, enforcement activity, and consumer protection litigation when they arise. He has worked with clients on numerous internal investigations and responses to Office of Inspector General (OIG) and US Department of Justice (DOJ) subpoenas and has assisted in the defense and settlement of qui tam whistleblower suits alleging violations of the False Claims Act.

Jamie is a recognized thought leader in the health law and medical device spaces. He is a regular speaker at health and life sciences industry conferences and has served as an advisory board member to bio-innovation centers and trade media editorial boards.

Prior to joining McDermott Will & Schulte, Jamie served as leader of the FDA, healthcare, and consumer products compliance practice at a large international law firm.

See Less

• Represented leading regenerative medicine wound care manufacturer in obtaining a Biologics Licensing Application for novel oral wound treatment product*
• Defended ophthalmology practice in settlement of qui tam whistleblower action for anti-kickback and false claims violations*
• Counseled private equity groups in multiple platform acquisitions and roll-ups in various medical product and health services M&A transactions*
• Represented leading underwriter in over a billion dollars of biotech focused at-the-market (ATM) and follow-on public offerings*

*Matter handled prior to joining the firm.

See Less